Physiol Rev 103 (2), 11371191
PMC 5114298
It contains tirzepatide, a drug that acts on both GIP and GLP-1 receptors
Healing stimulus fades between sessions
The following individual and combined search terms were used: GLP-1, Semaglutide and Liraglutide, molecular mechanism, lipid metabolism, insulin metabolism, glucose homeostasis, energy expenditure obesity treatment, type 2 diabetes mellitus, side effects, clinical trials, treatment option, fatty liver disease, hypertension, neurodegenerative diseases, cardiovascular diseases, therapeutic options. Only articles published in the last 10 years are included, although older pivotal studies were added
Some patients obtain prescriptions through telehealth services with minimal evaluation, raising safety concerns